A detailed history of Caption Management, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 18,500 shares of RLAY stock, worth $78,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,500
Holding current value
$78,255
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.23 - $9.51 $43,610 - $66,570
7,000 New
7,000 $49,000
Q1 2023

May 15, 2023

BUY
$15.0 - $22.76 $382,305 - $580,084
25,487 New
25,487 $419,000
Q2 2022

Aug 15, 2022

SELL
$13.31 - $34.88 $66,550 - $174,400
-5,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$20.26 - $32.36 $101,300 - $161,800
5,000 New
5,000 $149,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $509M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.